Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant by Earnshaw, W. C. et al.
 
Esperanto for histones: CENP-A, not CenH3, is the
centromeric histone H3 variant
 
 
(Article begins on next page)
The Harvard community has made this article openly
available.
Please share how this access benefits you. Your story
matters.
Citation Earnshaw, W. C., R. C. Allshire, B. E. Black, K. Bloom, B.
R. Brinkley, W. Brown, I. M. Cheeseman, et al. 2013.
Esperanto for histones: cenp-a, not cenh3, is the
centromeric histone h3 variant. Chromosome Research
21(2): 101-106.
Published
Version
doi:10.1007/s10577-013-9347-y
Accessed February 19, 2015 12:05:43 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11179848
Terms of Use This article was downloaded from Harvard University's
DASH repository, and is made available under the terms
and conditions applicable to Other Posted Material, as set
forth at http://nrs.harvard.edu/urn-
3:HUL.InstRepos:dash.current.terms-of-use#LAAEsperanto for histones: CENP-A, not CenH3,
is the centromeric histone H3 variant
W. C. Earnshaw & R. C. Allshire & B. E. Black & K. Bloom & B. R. Brinkley &
W. Brown & I. M. Cheeseman & K. H. A. Choo & G. P. Copenhaver & J. G. DeLuca &
A. Desai & S. Diekmann & S. Erhardt & M. Fitzgerald-Hayes & D. Foltz & T. Fukagawa &
R. Gassmann & D. W. Gerlich & D. M. Glover & G. J. Gorbsky & S. C. Harrison &
P. Heun & T. Hirota & L. E. T. Jansen & G. Karpen & G. J. P. L. Kops &
M. A. Lampson & S. M. Lens & A. Losada & K. Luger & H. Maiato & P. S. Maddox &
R. L. Margolis & H. Masumoto & A. D. McAinsh & B. G. Mellone & P. Meraldi &
A. Musacchio & K. Oegema & R. J. O’Neill & E. D. Salmon & K. C. Scott &
A. F. Straight & P. T. Stukenberg & B. A. Sullivan & K. F. Sullivan & C. E. Sunkel &
J. R. Swedlow & C. E. Walczak & P. E. Warburton & S. Westermann & H. F. Willard &
L. Wordeman & M. Yanagida & T. J. Yen & K. Yoda & D. W. Cleveland
Received: 15 March 2013 /Revised: 17 March 2013 /Accepted: 17 March 2013 /Published online: 12 April 2013
# The Author(s) 2013. This article is published with open access at Springerlink.com
Abstract The first centromeric protein identified in
any species was CENP-A, a divergent member of the
histone H3 family that was recognised by autoanti-
bodies from patients with scleroderma-spectrum dis-
ease. It has recently been suggested to rename this
protein CenH3. Here, we argue that the original name
should be maintained both because it is the basis of a
long established nomenclature for centromere proteins
and because it avoids confusion due to the presence of
canonical histone H3 at centromeres.
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Since the time of Linnaeus, scientific nomenclature
has been based on precedent. Over the past several
centuries, the tried and proven path to naming a spe-
cies (or more recently, a protein) is first to discover
one and then name it. In recent years, the rush of
scientific progress, with multiple groups often simul-
taneously discovering and naming the same protein at
the same time, has stressed the naming convention,
and occasionally, groups of scientists have stepped in
to rationalise the nomenclature.
In 2012, an article entitled ‘A unified phylogeny-
based nomenclature for histone variants’ appeared in
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28029 Madrid, Spainthe journal Epigenetics and Chromatin (Talbert et al.
2012). This article had a lengthy list of distinguished
authors from the chromatin/epigenetics community
and represents an effort to unify the histone nomen-
clature. This proposed simplification of naming his-
tone variants follows on the heels of a number of
previous distinguished efforts, including the rational-
isation of the caspase nomenclature in 1996 (Alnemri
et al. 1996), and a proposed standard nomenclature for
the kinesin proteins (Lawrence et al. 2004). The
caspase proposal was universally adopted almost im-
mediately, as the ten different caspases were known by
a host of confusing names at that time. The kinesin
article also has been widely influential.
While the proposal to unify the histone nomencla-
ture may have much to recommend it, with respect to
the specialized histone H3 variant found at all active
centromeres from budding yeast to human, we sug-
gest, for the reasons detailed below, that the scientific
community should maintain the original nomenclature
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Esperanto for histones: CENP-A is centromeric histone H3 variant 103(CENP-A) that was established for the centromeric
histone H3 variant and avoid the usage of the mislead-
ing name (CenH3) proposed by Talbert et al. (2012).
The first known centromeric protein was discovered
in human cells and named CENP-A in 1985 (Earnshaw
and Rothfield 1985). CENP-A was shown to be a
histone in 1991 by the late Doug Palmer, working with
Bob Margolis (Palmer et al. 1991). This conclusion
was subsequently confirmed when the protein was
cloned by Kevin Sullivan and colleagues (Sullivan et
al. 1994). CENP-A has been widely referred to by this
name over the subsequent 28 years, and the CENP
nomenclature has now been extended as far as
CENP-X for well-studied proteins.
It has now been suggested (Talbert et al. 2012) that
the name CENP-A should be superseded by CenH3 so
as to simplify multiple names now in use in multiple
species for the histone H3 variant found only at active
centromeres. The budding yeast homolog of CENP-A,
CSE4, was described in 1995 (Stoler et al. 1995), as
the product of the Cse4 gene, which was discovered in
a screen for mutations that affected chromosome seg-
regation. A later addition was the Drosophila homo-
logue, discovered in 2000 by homology with CENP-A
and then named Cid (Henikoff et al. 2000). It is an
important distinction to Drosophila geneticists that
Cid was not named because of a pre-existing named
mutation (in which case this name would have been
retained by tradition). To the contrary, Cid was iden-
tified on the basis of sequence similarity and was
known from the outset to be the Drosophila variant
of CENP-A.
The name proposed in Talbert et al., CenH3, adds
an unnecessary layer of confusion that is scientifically
misleading: its use implies that this protein is the
centromeric histone H3. This is simply not correct. A
range of studies has revealed that regional centromeres
contain not only CENP-A, but also lots of canonical
histone H3. This canonical centromeric histone H3 is
not just a ‘stuffer’ or contaminant of centromere chro-
matin. Studies ranging from biochemical fractionation
(Ando et al. 2002; Foltz et al. 2006; Hori et al. 2008)
to high-resolution light microscopy (Blower et al.
2002; Sullivan and Karpen 2004; Ribeiro et al. 2010)
reveal that centromeric canonical H3 nucleosomes are
interspersed with CENP-A nucleosomes and that spe-
cific components (e.g. CENP-C and the histone fold-
containing CENP-T/W complex-Nishino et al. 2012)
that make meaningful contacts with centromeric H3-
containing chromatin are important for kinetochore
assembly and function (Ohzeki et al. 2012). In fact,
the interspersed H3 chromatin may represent a distinct
chromosome domain, as it is post-translationally mod-
ified in a pattern that is distinct from both canonical
heterochromatinandeuchromatin(SullivanandKarpen
2004). Recognising this, the term ‘CenH3’ would more
appropriately refer to centromere-associated canonical
histone H3 than it does to the centromere-specific
CENP-A. Correspondingly, it is inappropriate as a
name for the histone H3 variant that is found exclusive-
ly at centromeres.
While we appreciate the overall efforts to unify the
nomenclature of histones from a phylogenetic perspec-
tive, our view is that the proposal by the many
chromatin-oriented authors of the Epigenetics and
Chromatin article (Talbert et al. 2012) to rename
CENP-A as CenH3 does not take into account the
extensive preceding literature on centromeres or kinet-
ochores, or the scientific confusion raised by such a
change. It is notable that while the signatories to this
Commentary have been primary contributors to the
centromere literature and all of us have published (some
extensively) on CENP-A, none of us was consulted
concerning the Epigenetics and Chromatin nomencla-
ture proposal. As systems and other forms of integrative
biology become increasingly prevalent and communi-
tiesthatdonotnormallyinteractarebroughtintocontact
(and potential conflict), other nomenclature issues such
as this will arise when the same protein means different
things to diverse groups of scientists. Thus, the impor-
tance of cross-communication between communities
and respect for precedence in naming (in this case, the
precedence of the well-established CENP nomencla-
ture) may actually increase over the next few years.
Bearing in mind the confusion that will inevitably
arise over whether the term CenH3 refers to canonical
histone H3interspersed with CENP-Aatcentromeres or
to the CENP-A itself, we recommend that the proposed
name CenH3 be abandoned and that this important
marker for centromeric chromatin should be referred to
by the name originally given to it in 1985—CENP-A.
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